Terms ending in 2032
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,570,211 | Antibodies Selective for Cells Presenting Egfr at High Density In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,084,510 | Antibodies Selective for Cells Presenting Egfr at High Density In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 9,090,642 | Methods for the Preparation of Diasteromerically Pure Phosphoramidate Prodrugs In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,102,614 | NAPHTH-2-Ylacetic Acid Derivatives to Treat Aids In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,703,759 | Fused Heterocyclic Compounds as Ion Channel Modulators In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,065,958 | Methods and Compounds for Treating Paramyxoviridae Virus Infections In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 8,841,275 | 2'-Spiro-nucleosides and Derivatives Thereof Useful for Treating Hepatitis C Virus and Dengue Virus Infections In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,800,857 | Antibodies to Matrix Metalloproteinase 9 In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 9,296,758 | 2-Quinolinyl-ACETIC Acid Derivatives as HIV Antiviral Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 8,877,733 | 1'-Substituted Pyrimidine N-Nucleoside Analogs for Antiviral Treatment In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| 49 more term ends in 2032 · Pro | |||||
10 of 59 patents shown. Soonest term end first, then patent number.
Pro members see all 59.
56 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.